Mizuho Securities USA’s Charles River Laboratories CRL Stock Holding History

Mizuho Securities USA’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$855K	Buy	3,771 +796	+27%	+$142K	0.01%	610
2026 Q1	$513K	Sell	2,975 -609	-17%	-$113K	0.01%	635
2025 Q4	$638K	Hold	3,584	–	–	0.01%	640
2025 Q3	$585K	Buy	3,584 +191	+6%	+$30.3K	0.01%	652
2025 Q2	$515K	Sell	3,393 -701	-17%	-$93.5K	0.01%	628
2025 Q1	$616K	Sell	4,094 -753	-16%	-$126K	0.01%	591
2024 Q4	$895K	Buy	4,847 +1,499	+45%	+$289K	0.02%	548
2024 Q3	$659K	Sell	3,348 -628	-16%	-$131K	0.01%	550
2024 Q2	$821K	Buy	+3,976	New	+$901K	0.02%	536

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mizuho Securities USA's CRL Position: Q2 2026 in Review

Mizuho Securities USA increased its Charles River Laboratories (CRL) stake by 27% in Q2 2026, buying an estimated $142K and bringing the position to 3,771 shares worth $855K. The position accounts for 0.01% of the portfolio, ranked #610.

Mizuho Securities USA first reported a position in CRL in Q2 2024 and has held it in 9 quarters since. The position peaked at $895K in Q4 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Mizuho Securities USA held 3,771 shares of Charles River Laboratories worth $855K as of Q2 2026.
Mizuho Securities USA bought 796 Charles River Laboratories shares in Q2 2026, an estimated $142K.
Charles River Laboratories made up 0.01% of Mizuho Securities USA's portfolio in Q2 2026, its #610 holding.
Mizuho Securities USA first reported a position in Charles River Laboratories in Q2 2024 and has held it in 9 quarters since.
Mizuho Securities USA's Charles River Laboratories position peaked at $895K in Q4 2024.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.